In line with our expectations, the levels of the pro-inflammatory cytokines TNF-α, IL-1β, and IL-6 were decreased after the ketamine infusions in our study, which is consistent with the results of previous studies31–34 that administered a single infusion in patients with depression. This evidence concerns the gene IL1B and major depressive disorder.